UAN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. UAN’s trend is bullish, but it’s extended (RSI ~70) and there’s a near-term fundamental overhang from the sharp projected drop in ammonia utilization (60–65% vs 96% YoY) ahead of the 2026-02-17 earnings. With no Intellectia buy signals today and an impatient entry profile, the risk/reward favors waiting rather than buying at ~103.6 after a strong run.
Trend/price action: Bullish structure with moving averages stacked positively (SMA_5 > SMA_20 > SMA_200), indicating an ongoing uptrend despite today’s -1.66% regular-session dip.
Momentum: MACD histogram +0.436 and expanding, consistent with upside momentum.
Overbought risk: RSI_6 at 70.639 suggests the stock is stretched and prone to pullbacks rather than offering a clean, low-risk entry.
Levels: Pivot/support area 92.451 (with nearby S1 ~90.546). Immediate resistance levels listed (R1 ~94.356, R2 ~95.533) are already below the current price (103.57), implying price is extended beyond the provided pivot framework and may mean-revert toward prior support.
Pattern-based bias: Similar-pattern stats show slightly negative next day/week (-0.46% / -0.78%) and modestly positive next month (+1.3%).
Intellectia Proprietary Trading Signals
with large YoY gains in revenue, margins, EPS, and net income.
and is prone to a fast pullback, which is unfavorable for an impatient entry.
Latest quarter: 2025/Q3. Growth trends: Revenue rose to 163,549,000 (+30.63% YoY). Net income increased to 43,072,000 (+1031.39% YoY). EPS increased to 4.07 (+1030.56% YoY). Gross margin improved to 37 (+151.19% YoY). Overall, the last reported quarter shows strong acceleration, but the more recent utilization guidance in the news suggests the next prints may not look as strong.
No analyst rating or price target change data was provided, so a formal trend can’t be confirmed. Wall Street-style pros/cons based on available info: Pros: Strong last reported quarter (2025/Q3) and improving margins; fertilizer/ammonia exposure can deliver outsized cash flows when conditions are favorable. Cons: Operational/utilization guidance points to weaker near-term fundamentals; earnings/distribution variability risk is elevated into the next report. Influential buying/selling: Hedge funds and insiders are listed as neutral; no recent congress trading data available.
